Key result
Corrodible iron stents achieve 100% patency with no thromboembolic events in rabbit aortas.
Answers are grounded in this paper and cite their sources.
OBJECTIVE: To determine whether corrodible materials may be safely used as biodegradable cardiovascular implants. DESIGN: Corrodible iron stents (> 99.8% iron) were produced from pure iron and laser cut with a stent design similar to a commercially available permanent stent (PUVA-AS16). A total of 16 NOR-I stents were implanted into the native descending aorta of 16 New Zealand white rabbits (mean luminal diameter at the implantation site 3.4 mm, balloon diameter to vessel diameter ratio 1.13). RESULTS: No thromboembolic complications and no adverse events occurred during the follow up of 6-18 months. All stents were patent at repeat angiography after 6 (n = 9), 12 (n = 5), and 18 months (n = 2) with no significant neointimal proliferation, no pronounced inflammatory response, and no systemic toxicity. CONCLUSIONS: This initial in vivo experience suggests that degradable iron stents can be safely implanted without significant obstruction of the stented vessel caused by inflammation, neointimal proliferation, or thrombotic events.
No takes yet. Share an insight, caveat, or question.
Matthias Peuster (2001) studied Native descending aorta stenting (preclinical animal model) (n=16). Corrodible iron stent (NOR-I, >99.8% pure iron) was evaluated on Stent patency and absence of thromboembolic complications or adverse events. Corrodible iron stents implanted in rabbit aortas maintained 100% patency (16/16) with 0% thromboembolic or adverse events over 6-18 months of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: